TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

DORYX

DOXYCYCLINE HYCLATE
Approved 1985-07-22
7
Indications
--
Phase 3 Trials
1
Priority Reviews
40
Years on Market

Details

Status
Discontinued
First Approved
1985-07-22
Routes
ORAL
Dosage Forms
CAPSULE, DELAYED RELEASE, TABLET, DELAYED RELEASE

Companies

Active Ingredient: DOXYCYCLINE HYCLATE

DORYX Approval History

Loading approval history...

What DORYX Treats

7 FDA approvals

Originally approved for its first indication in 1985 . Covers 7 distinct patient populations.

  • Other (7)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DORYX FDA Label Details

Pro

DORYX Patents & Exclusivity

Latest Patent: Dec 2034

Patents (84 active)

US9446057 Expires Dec 23, 2034
US9295652 Expires Oct 23, 2034
US9511031 Expires Oct 23, 2034
US8715724 Expires Feb 3, 2028
+ 74 more patents
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.